These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hypolipidaemic agents: What are they good for? Manninen V; Mälkönen M; Tuomilehto J Lancet; 1977 Dec; 2(8051):1281-2. PubMed ID: 73969 [No Abstract] [Full Text] [Related]
3. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias. Jepson EM; Small E; Grayson MF; Bance G; Billimoria JD Atherosclerosis; 1972; 16(1):9-14. PubMed ID: 4341723 [No Abstract] [Full Text] [Related]
5. Clofibrate and related compounds in hyperlipoproteinaemia. A review. Gustafson A Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983 [No Abstract] [Full Text] [Related]
6. Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation to clofibrate trial. Carlson LA; Olsson AG Lancet; 1979 Apr; 1(8121):869-70. PubMed ID: 86108 [No Abstract] [Full Text] [Related]
7. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. Kesäniemi YA; Grundy SM JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of primary hyperlipoproteinaemia types, IIa, IIb, 3 and IV with clofibrate (author's transl)]. von Löwis P; Klemens UH Dtsch Med Wochenschr; 1973 Dec; 98(49):2328-33. PubMed ID: 4357927 [No Abstract] [Full Text] [Related]
9. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)]. Weisweiler P; Schwandt P Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601 [TBL] [Abstract][Full Text] [Related]
10. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia. Patsch JR; Yeshurun D; Jackson RL; Gotto AM Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188 [No Abstract] [Full Text] [Related]
11. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451 [No Abstract] [Full Text] [Related]
12. Dietary and drug treatment of primary hyperlipoproteinemia. Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081 [No Abstract] [Full Text] [Related]
13. Secholex, Clofibrate and taurine in hyperlipidaemia. Howard AN; Evans RJ Atherosclerosis; 1974; 20(1):105-16. PubMed ID: 4376405 [No Abstract] [Full Text] [Related]
14. One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia. Olsson AG; Lang PD Atherosclerosis; 1978 Dec; 31(4):429-33. PubMed ID: 215175 [TBL] [Abstract][Full Text] [Related]
15. Does hypolipidemic therapy prevent coronary heart disease? Rifkind BM; Levy RI Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303 [No Abstract] [Full Text] [Related]
16. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia. Miettinen TA; Penttilä IM; Lampainen E Acta Med Scand; 1972 Sep; 192(3):177-82. PubMed ID: 4341290 [No Abstract] [Full Text] [Related]
17. Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinanemia. Olsson AG; Lang PD Atherosclerosis; 1978 Dec; 31(4):421-8. PubMed ID: 215174 [TBL] [Abstract][Full Text] [Related]
18. Management of hyperlipidemias. Murphy BF JAMA; 1974 Dec 23-30; 230(12):1683-91. PubMed ID: 4373590 [No Abstract] [Full Text] [Related]
19. Treatment of hyperlipidemia. Levy RI; Morganroth J; Rifkind BM N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888 [No Abstract] [Full Text] [Related]
20. [Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias]. Krivoruchenko IV; Nikul'cheva NG Kardiologiia; 1976 Jul; 16(7):71-5. PubMed ID: 185448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]